Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Talis Biomedical Corp changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 45 | 43 | −2 |
| Shares | 20.9M | 19.6M | −1.34M (−6.4%) |
| Value | $269.0M | $184.0M | −$85.0M (−31.6%) |
New holders (5)
Institutions that held Talis Biomedical Corp at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 29,636 | $327.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 22,920 | $253.0K | 0.00% |
| Legato Capital Management LLC | 18,585 | $205.0K | 0.03% |
| Millennium Management LLC | 14,219 | $157.0K | 0.00% |
| Rhumbline Advisers | 12,976 | $143.0K | 0.00% |
Sold out (7)
Institutions that held Talis Biomedical Corp at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Sectoral Asset Management Inc | 405,094 | $5.21M |
| Perceptive Advisors LLC | 250,000 | $3.21M |
| Caas Capital Management LP | 40,000 | $514.0K |
| Tudor Investment Corp Et Al | 10,000 | $129.0K |
| Laurion Capital Management LP | 10,000 | $129.0K |
| STRS Ohio | 3,200 | $41.0K |
| Bank of Montreal | 432 | $6.00K |